12296-0 |
Mescaline |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Mescaline [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12296-0 |
|
|
|
|
Both |
|
|
|
0 |
Mescaline Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Peyote; Peyotl; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12297-8 |
Chlorate |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Chlorate [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12297-8 |
|
|
|
|
Both |
|
|
|
0 |
Chlorate Bld Ql |
|
|
|
|
|
Blood; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12298-6 |
Erythromycin |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Erythromycin [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12298-6 |
|
|
|
|
Both |
|
|
|
0 |
Erythromycin Ur Ql |
|
|
|
|
|
c212; DRUG/TOXICOLOGY; Drugs; EES; Erygel; Erythromycn; Ilosone; Ilotycin; Iltycin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12299-4 |
Ethinamate |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Ethinamate [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12299-4 |
|
|
|
|
Both |
|
|
|
0 |
Ethinamate Ur Ql |
|
|
|
|
|
1-Ethynylcyclohexanol carbamate; C9H13NO2; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Valmid |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
123-0 |
Cefprozil |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
123-0 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Cefprozil Islt MLC |
|
|
|
Y |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefzil; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
1230-2 |
M Ag |
PrThr |
RBC^Donor |
Pt |
Ord |
|
|
ACTIVE |
M Ag [Presence] on Red Blood Cells from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1230-2 |
|
|
|
|
Observation |
|
|
|
0 |
M Ag RBC Donr Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Donr; Erythrocytes; Hematology; Heme; MNSs Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12300-0 |
Polythiazide |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Polythiazide [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12300-0 |
|
|
|
|
Both |
|
|
|
0 |
Polythiazide Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12301-8 |
Procaine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Procaine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12301-8 |
|
|
|
|
Both |
|
|
|
0 |
Procaine Ur Ql |
|
|
|
|
|
c217; c284; c83; DRUG/TOXICOLOGY; Drugs; Novocaine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12302-6 |
Theobromine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Theobromine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12302-6 |
|
|
|
|
Both |
|
|
|
0 |
Theobromine SerPl Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12303-4 |
Theobromine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Theobromine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12303-4 |
|
|
|
|
Both |
|
|
|
0 |
Theobromine Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12304-2 |
Benzyl alcohol |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Benzyl alcohol [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12304-2 |
|
|
|
|
Both |
|
|
|
0 |
Benzyl Alc SerPl Ql |
|
|
|
|
|
Alc; alcoholic; DRUG/TOXICOLOGY; Drugs; Hydroxytoluene; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12305-9 |
Chlordecone |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Chlordecone [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12305-9 |
|
|
|
|
Both |
|
|
|
0 |
Chlordecone Bld Ql |
|
|
|
|
|
Blood; DRUG/TOXICOLOGY; Drugs; Kepone; Merck#2053; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12306-7 |
Cyclohexane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Cyclohexane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
12306-7 |
|
|
|
|
Both |
|
|
|
0 |
Cyclohexane Bld-mCnc |
|
|
|
Y |
|
Benzenehexahydride; Blood; C6H12; DRUG/TOXICOLOGY; Drugs; Hexahydro-benzene; Hexamethylene; Hexanaphthene; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
12307-5 |
Dichloroethane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Dichloroethane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
12307-5 |
|
|
|
|
Both |
|
|
|
0 |
DCA Bld-mCnc |
|
|
|
Y |
|
Blood; DCA; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
12308-3 |
HYDROcodone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
HYDROcodone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12308-3 |
|
|
|
|
Both |
|
|
|
0 |
HYDROcodone Ur Ql |
|
|
|
|
|
Addiction; Anexsia; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn; Vicodin |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12309-1 |
Naltrexone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Naltrexone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12309-1 |
|
|
|
|
Both |
|
|
|
0 |
Naltrexone Ur Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Revia; Screen; UA; UR; Urn; Vivitrol |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1231-0 |
M Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
M Ag [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1231-0 |
|
|
|
|
Both |
|
|
|
0 |
M Ag RBC Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; MNSs Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12310-9 |
Phenytoin |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Phenytoin [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12310-9 |
|
|
|
|
Both |
|
|
|
0 |
Phenytoin Ur Ql |
|
|
|
|
|
DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Ordinal; Phenhydan; PHYT; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sinergina; UA; UR; Urn; Zentropil |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12311-7 |
Prazepam |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Prazepam [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
12311-7 |
|
|
|
|
Both |
|
|
|
0 |
Prazepam Ur-mCnc |
|
|
|
Y |
|
Centrax; Demetrin; DRUG/TOXICOLOGY; Drugs; Level; Lysanxia; Mass concentration; Mono-detrimin; Point in time; Prazene; QNT; Quan; Quant; Quantitative; Random; Reapam; Trepidan; UA; UR; Urn |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
12312-5 |
Cyclopropane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Cyclopropane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
12312-5 |
|
|
|
|
Both |
|
|
|
0 |
Cyclopropane Bld-mCnc |
|
|
|
Y |
|
Blood; C3H6; DRUG/TOXICOLOGY; Drugs; HEF; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
12313-3 |
Aprobarbital |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Aprobarbital [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12313-3 |
|
|
|
|
Both |
|
|
|
0 |
Aprobarbital Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Oramon; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12314-1 |
Clorazepate |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Clorazepate [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12314-1 |
|
|
|
|
Both |
|
|
|
0 |
Clorazepate Ur Ql |
|
|
|
|
|
Chlorazepate; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tranxene; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12315-8 |
Mephobarbital |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Mephobarbital [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12315-8 |
|
|
|
|
Both |
|
|
|
0 |
Mephobarbital Ur Ql |
|
|
|
|
|
Barbiturate; DRUG/TOXICOLOGY; Drugs; Mebaral; Methylphenobarbital; Ordinal; Phenitone; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12316-6 |
Methopyrilene |
ACnc |
Urine |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Methapyrilene [Presence] in Urine |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12316-6 |
|
|
|
|
|
|
|
|
0 |
Deprecated Methopyrilene Ur Ql |
|
|
|
|
|
Arbitrary concentration; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.36 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12317-4 |
Phenolphthalein |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Phenolphthalein [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12317-4 |
|
|
|
|
Both |
|
|
|
0 |
Phenolphthalein Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Phenolthalein; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |